Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03748706 · ClinicalTrials.gov registry record · Phase 2
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
A Phase 2 study, sponsored by Pain Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT03748706 is a Phase 2 study that has completed, run by Pain Therapeutics. The registered enrollment target is 13 participants.
The verdict
NCT03748706, a Phase 2 study, has completed, sponsored by Pain Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is a Phase 2a, multi-center, open-label study of PTI-125 in mild-to-moderate Alzheimer's disease patients.
Interventions
- DRUG PTI-125, 100 mg tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-03-07 |
| Est. Completion | 2019-05-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03748706
The ClinicalTrials.gov registry entry for NCT03748706 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pain Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PTI-125, 100 mg tablets is the first listed.
NCT03748706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03748706 about?
NCT03748706 is a clinical study titled "PTI-125 for Mild-to-moderate Alzheimer's Disease Patients". This is a Phase 2a, multi-center, open-label study of PTI-125 in mild-to-moderate Alzheimer's disease patients.
What is the current status of trial NCT03748706?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2019-03-07. Estimated completion is 2019-05-08.
What interventions are being tested in trial NCT03748706?
The interventions under investigation include: PTI-125, 100 mg tablets (DRUG).
Who is sponsoring clinical trial NCT03748706?
This trial is sponsored by Pain Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.